Background and objective Alzheimer's disease (AD) and frontotemporal dementia (FTD)
show different patterns of cortical thickness (CTh) loss compared with healthy controls (HC) …

In this study, we analyzed differences in cortical thickness (CTH) between healthy controls
(HC), subjects with stable mild cognitive impairment (S-MCI), progressive MCI (P-MCI), and …

Objective Analyzing neuroimages being useful method in the field of neuroscience and
neurology and solving the incompatibilities across protocols and vendors have become a …

Alzheimer's disease and frontotemporal dementia (FTD) can be difficult to differentiate
clinically because of overlapping symptoms. Distinguishing the two dementias based on …

Objectives To assess and compare cortical thickness (CTh) of patients with prodromal
Dementia with Lewy bodies (pro-DLB), prodromal Alzheimer's disease (pro-AD), DLB …

Mild cognitive impairment (MCI) is a transition between normal cognition (NC) and
Alzheimer's disease (AD). Differences in cortical thickness (ΔCT) have been reported in …

Introduction Cortical thickness has been proposed as a biomarker of Alzheimer's disease
(AD)–related neurodegeneration, but the nature of its relationship with amyloid beta (Aβ) …

Background and Objectives Alzheimer disease (AD) is highly heterogeneous, with marked
individual differences in clinical presentation and neurobiology. To explore this, we used …

ABSTRACT BACKGROUND AND PURPOSE Automated cortical thickness (CT)
measurements are often used to assess gray matter changes in the healthy and diseased …

Cortical thickness analysis has been proposed as a potential diagnostic measure in memory
disorders. In this retrospective study, we compared the cortical thickness values of 24 …